Viva Zome CEO David Haylock is presenting at the Annual Conference of the American Society of Gene and Cell Therapy on 13 May 2021 in an Industrial Symposium sponsored by Pall Corporation. His presentation is entitled “Exosome manufacture in a fixed-bed bioreactor, and overcoming production challenges” Read more at http://vivazome.com/wp-content/uploads/2021/05/VivaZome-ASGCT-release-11-May-2021.pdf